Merck
Index129390. Sampaio et al (1991) Thalidomide
selectively inhibits tumor necrosis factor α production by stimulated human monocytes.
J.Exp.Med. 173 699. Makonkawkeyoon et al (1993)
Thalidomide inhibits the replication of human-immunodeficiency-virus type 1.
Proc.Natl.Acad.Sci.USA 90 5974. Kanbayashiet al
(1996) Thalidomide, a hypnotic with immune modulating properties, increases
cataplexy in canine narcolepsy. Neuroreport 7 1881. Boireauet al (1997) Thalidomide reduces MPTP-induced decrease in striatal
dopamine levels in mice. Neurosci.Lett. 234 123.